Northern Trust’s Monte Rosa Therapeutics GLUE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$13.6M	Buy	826,624 +129,590	+19%	+$2.48M	﹤0.01%	1906
2025 Q4	$10.9M	Sell	697,034 -43,650	-6%	-$588K	﹤0.01%	2033
2025 Q3	$5.49M	Sell	740,684 -20,735	-3%	-$110K	﹤0.01%	2448
2025 Q2	$3.43M	Buy	761,419 +388,212	+104%	+$1.73M	﹤0.01%	2690
2025 Q1	$1.73M	Sell	373,207 -3,757	-1%	-$23K	﹤0.01%	2996
2024 Q4	$2.62M	Buy	376,964 +18,391	+5%	+$138K	﹤0.01%	2862
2024 Q3	$1.9M	Buy	358,573 +64,377	+22%	+$325K	﹤0.01%	3036
2024 Q2	$1.1M	Buy	294,196 +3,742	+1%	+$19.1K	﹤0.01%	3200
2024 Q1	$2.05M	Buy	290,454 +5,520	+2%	+$32.7K	﹤0.01%	2948
2023 Q4	$1.61M	Sell	284,934 -159,028	-36%	-$624K	﹤0.01%	3107
2023 Q3	$2.13M	Buy	443,962 +15,473	+4%	+$99.6K	﹤0.01%	2905
2023 Q2	$2.94M	Buy	428,489 +177,962	+71%	+$1.15M	﹤0.01%	2792
2023 Q1	$1.95M	Sell	250,527 -4,584	-2%	-$31.9K	﹤0.01%	2946
2022 Q4	$1.94M	Buy	255,111 +6,961	+3%	+$58K	﹤0.01%	3015
2022 Q3	$2.03M	Buy	248,150 +24,385	+11%	+$224K	﹤0.01%	3003
2022 Q2	$2.16M	Buy	223,765 +4,027	+2%	+$40.5K	﹤0.01%	3015
2022 Q1	$3.08M	Buy	219,738 +111,573	+103%	+$1.55M	﹤0.01%	2867
2021 Q4	$2.21M	Buy	108,165 +4,168	+4%	+$87.3K	﹤0.01%	3176
2021 Q3	$2.32M	Buy	+103,997	New	+$2.98M	﹤0.01%	3213